Nitroglycerin plus clopidogrel for acute myocardial infarction and the effect on cardiac function indices

Area of Science:

• Cardiology
• Pharmacology

Background:

• Acute myocardial infarction (AMI) is a leading cause of mortality worldwide.
• Effective therapeutic strategies are crucial for improving patient outcomes and cardiac function.

Purpose of the Study:

• To evaluate the efficacy of nitroglycerin combined with clopidogrel in treating acute myocardial infarction.
• To assess the impact of this combination therapy on cardiac function indices and overall patient well-being.

Main Methods:

• A study involving 90 acute myocardial infarction patients, divided into a control group (clopidogrel) and an experimental group (nitroglycerin plus clopidogrel).
• Outcome measures included clinical efficacy, inflammatory factors, cardiac function indices (e.g., ESVI, EDVI), myocardial enzymatic indexes, QRS scores, infarct size, and quality of life (SF-36).

Main Results:

• The combination of nitroglycerin and clopidogrel demonstrated significantly higher clinical efficacy compared to clopidogrel alone (P<0.05).
• Patients receiving the combined therapy showed reduced inflammatory markers, smaller myocardial infarction areas, improved cardiac function (lower ESVI, higher EDVI), and better quality of life scores.
• The combination therapy also led to lower myocardial enzymatic indexes and QRS scores.

Conclusions:

• Nitroglycerin plus clopidogrel effectively ameliorates cardiac function indices in acute myocardial infarction patients.
• This combination mitigates inflammatory responses and improves patient quality of life.
• Further research is recommended before widespread clinical adoption.